Vestrant 250mg Injection
Marketer
Getwell Pharma (I) Pvt Ltd
Salt Composition
Fulvestrant (250mg)
Overview Vestrant 250mg Injection
Fulvestrant 250mg injection acts as an estrogen receptor antagonist. This medication treats breast cancer in postmenopausal women by regulating estrogen levels and inhibiting cancer cell proliferation. Administered intramuscularly under medical supervision, the dosage and frequency are determined by the treating physician based on individual patient needs and treatment goals. Treatment duration adheres to the physician's prescription. Commonly reported adverse effects include injection site reactions, headache, nausea, vomiting, and allergic reactions. Patients should report any concerning or persistent side effects to their physician; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions, bleeding disorders, history of anticoagulant use, and all other concurrent medications, as interactions may impact efficacy or alter the drug's effects. Disclose any pregnancy, pregnancy plans, or breastfeeding status to your physician.
Primary Ingredients of Vestrant 250mg Injection
There is no text provided to rephrase.
Uses of Vestrant 250mg Injection
Malignant breast tumor
Major Benefits of Vestrant 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vestrant 250mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Vestrant 250mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vestrant 250mg Injection works:
Vestrant 250mg Injection inhibits estrogen's effects on breast cancer cells, potentially suppressing or halting the proliferation of estrogen-dependent tumors.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside Vestrant 250mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Vestrant 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Vestrant 250mg Injection is contraindicated while breastfeeding due to potential infant toxicity indicated by available data.
DrivingSAFE
Driving ability is typically unaffected by a 250mg Vestrant injection.
KidneyCAUTION
Vestrant 250mg Injection requires careful administration in individuals with severe kidney impairment; dosage modification may be necessary. Patients should seek medical advice. Data regarding Vestrant 250mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney disease.
LiverCAUTION
Patients with liver impairment should use the 250mg Vestrant injection cautiously; dose modification may be necessary. Physician consultation is advised.
What if you forget to take Vestrant 250mg Injection :
Should you forget a Vestrant 250mg Injection, seek your physician's advice.
Facts to Know About Vestrant 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Estrogen Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Estrogen receptor blocker |
3,018 People bought this recently